Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 63629-8472

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 63629-8472). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-01 (Figure 01)

This text is a figure caption for a graph showing the effect of Atorvastatin Calcium 10 mg/day on the cumulative incidence of non-fatal myocardial infarction or coronary heart disease death in the ASCOT-LLA study. The graph shows a decrease in incidence with a hazard ratio of 0.64 and a p-value of 0.0005. Therefore, this text provides supporting evidence for the effectiveness of Atorvastatin Calcium in preventing heart disease.*

FDA Label Image

Figure-02 (Figure 02)

The figure shows the effect of daily intake of 10mg Atorvastatin Calcium on the time taken for the occurrence of major cardiovascular events such as myocardial infarction, acute CHD death, unstable angina, coronary revascularization, or stroke in CARDS. The graph displays the cumulative hazard percentage against the time to the first primary endpoint through four years of follow-up. The hazard ratio is 0.63, indicating a significant reduction in the risk of major cardiovascular events with the intake of Atorvastatin Calcium.*

FDA Label Image

Figure-03 (Figure 03)

This is a figure showing the effect of Atorvastatin Calcium doses of 80 mg/day vs 10 mg/day on the time to occurrence of major cardiovascular events. The percentages of subjects experiencing the event are displayed over time in years. The hazard ratio (HR) calculated between the two groups was 0.78, with a p-value of 0.0002, indicating a significant reduction in major cardiovascular events with higher dose of Atorvastatin Calcium.*

FDA Label Image

Chemical-structure (Chemical Structure)

FDA Label Image

Label (Lbl636298472)

Atorvastatin Calcium Tablets, USP is a medication that contains 80 mg of atorvastatin calcium per tablet. It should be kept out of reach of children and stored at controlled room temperature. It is dispensed in child-resistant containers. NDC 63629-8472-1 is the National Drug Code for this medication. It is available in film-coated tablets.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.